Show simple item record

dc.contributor.authorO'Brien, T
dc.contributor.authorChristrup, L L
dc.contributor.authorDrewes, A M
dc.contributor.authorFallon, M T
dc.contributor.authorKress, H G
dc.contributor.authorMcQuay, H J
dc.contributor.authorMikus, G
dc.contributor.authorMorlion, B J
dc.contributor.authorPerez-Cajaraville, J
dc.contributor.authorPogatzki-Zahn, E
dc.contributor.authorVarrassi, G
dc.contributor.authorWells, J C D
dc.date.accessioned2019-08-19T07:54:29Z
dc.date.available2019-08-19T07:54:29Z
dc.date.issued2017-01-01
dc.identifier.issn1532-2149
dc.identifier.pmid27991730
dc.identifier.pmidPMC6680203
dc.identifier.doi10.1002/ejp.970
dc.identifier.doihttps://doi.org/10.1002/ejp.970
dc.identifier.urihttp://hdl.handle.net/10147/624814
dc.descriptionPoorly controlled pain is a global public health issue. The personal, familial and societal costs are immeasurable. Only a minority of European patients have access to a comprehensive specialist pain clinic. More commonly the responsibility for chronic pain management and initiating opioid therapy rests with the primary care physician and other non-specialist opioid prescribers. There is much confusing and conflicting information available to non-specialist prescribers regarding opioid therapy and a great deal of unjustified fear is generated. Opioid therapy should only be initiated by competent clinicians as part of a multi-faceted treatment programme in circumstances where more simple measures have failed. Throughout, all patients must be kept under close clinical surveillance. As with any other medical therapy, if the treatment fails to yield the desired results and/or the patient is additionally burdened by an unacceptable level of adverse effects, the overall management strategy must be reviewed and revised. No responsible clinician will wish to pursue a failed treatment strategy or persist with an ineffective and burdensome treatment. In a considered attempt to empower and inform non-specialist opioid prescribers, EFIC convened a European group of experts, drawn from a diverse range of basic science and relevant clinical disciplines, to prepare a position paper on appropriate opioid use in chronic pain. The expert panel reviewed the available literature and harnessed the experience of many years of clinical practice to produce these series of recommendations. Its success will be judged on the extent to which it contributes to an improved pain management experience for chronic pain patients across Europe. SIGNIFICANCE: This position paper provides expert recommendations for primary care physicians and other non- specialist healthcare professionals in Europe, particularly those who do not have ready access to specialists in pain medicine, on the safe and appropriate use of opioid medications as part of a multi-faceted approach to pain management, in properly selected and supervised patients.en_US
dc.language.isoenen_US
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680203/en_US
dc.subjectResearch Subject Categories::MEDICINEen_US
dc.subjectChronic Pain/drug therapyen_US
dc.subjectAnalgesics, Opioiden_US
dc.subjectPAIN MANAGEMENTen_US
dc.subjectOPIOID USEen_US
dc.subject.otherClinical Protocolsen_US
dc.subject.otherPosition Paperen_US
dc.titleEuropean Pain Federation position paper on appropriate opioid use in chronic pain management.en_US
dc.typeArticleen_US
dc.contributor.departmentMarymount University Hospital & Hospiceen_US
dc.contributor.affiliationMarymount University Hospital & Hospice
dc.source.journaltitleEuropean journal of pain (London, England)
refterms.dateFOA2019-08-19T07:54:29Z


Files in this item

Thumbnail
Name:
EJP-21-3.pdf
Size:
344.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record